H.R. No. 550
R E S O L U T I O N
WHEREAS, Dr. Jennifer Keating Litton of The University of
Texas MD Anderson Cancer Center in Houston has distinguished
herself through her many contributions to cancer research and
treatment; and
WHEREAS, Over the course of her tenure at MD Anderson, Dr.
Litton has held numerous leadership positions, including chief of
the Section of Clinical Research and Drug Development in the
Department of Breast Medical Oncology, where she also served as an
associate professor; she has also spearheaded the Breast Medical
Oncology Education Program, the Scientific Review Research
Committee, and the Genitourinary Chair Search Committee; she
currently serves as vice president of clinical research, leading
the largest cancer clinical trials program in the country with more
than 1,500 clinical trials and over 10,000 patients enrolled in
therapeutic trials; moreover, she is a member of the faculty at the
UTHealth Houston Graduate School of Biomedical Sciences at MD
Anderson; and
WHEREAS, Dr. Litton has been involved in numerous committees
and organizations, including the Society for Immunotherapy of
Cancer, the American Society of Clinical Oncology, the Society of
Surgical Oncology, the American Society for Radiation Oncology, the
FORCE Advisory Board, the Clinical Cancer Genetics Steering
Committee, and Living Beyond Breast Cancer; she is also a member of
Suites of Hope in Houston and the Texas Lyceum in Austin; in 2018,
she received the President's Recognition of Faculty Excellence
Award in Prevention Outreach from MD Anderson; and
WHEREAS, Board certified in oncology and internal medicine,
Dr. Litton focuses her research on pregnancy and breast cancer,
genetic testing, and molecular changes of breast cancer genes; she
holds a bachelor's degree from Duke University, a doctor of
medicine degree from the University of Massachusetts Medical
School, and a master's degree in health care management from the
Harvard T. H. Chan School of Public Health; she completed her
residency and chief residency at the Baylor College of Medicine as
well as a fellowship in medical oncology at MD Anderson; and
WHEREAS, Through her leadership, skill, and commitment to
excellence, Dr. Litton has made a lasting and positive impact in her
field, and it is a privilege to join in recognizing this outstanding
professional; now, therefore, be it
RESOLVED, That the House of Representatives of the 89th Texas
Legislature hereby honor Dr. Jennifer Keating Litton for her many
professional achievements and extend to her sincere best wishes for
continued success; and, be it further
RESOLVED, That an official copy of this resolution be
prepared for Dr. Litton as an expression of high regard by the Texas
House of Representatives.
Johnson
______________________________
Speaker of the House
I certify that H.R. No. 550 was adopted by the House on March
31, 2025, by a non-record vote.
______________________________
Chief Clerk of the House